Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Time to Progression”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Testing effectiveness (Phase 2)Ended earlyNCT00570258
What this trial is testing

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Who this might be right for
Metastatic Breast Cancer
University of Arkansas 27
Large-scale testing (Phase 3)UnknownNCT04741438
What this trial is testing

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Who this might be right for
Sarcoma
Centre Leon Berard 96
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Not applicableActive Not RecruitingNCT07448493
What this trial is testing

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 230
Not applicableUnknownNCT00256672
What this trial is testing

Effectiveness of Bracing in Preventing Scoliosis in Children With Spinal Cord Injury

Who this might be right for
Scoliosis
Shriners Hospitals for Children 88
Not applicableLooking for participantsNCT07429851
What this trial is testing

CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Carcinoma of LungNeuroendocrine Carcinoma of Thymus
European Institute of Oncology 34
Not applicableStudy completedNCT00911105
What this trial is testing

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
iOMEDICO AG 101
Not applicableWithdrawnNCT02137811
What this trial is testing

Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)

Who this might be right for
Cancer
Pierian Biosciences
Testing effectiveness (Phase 2)Ended earlyNCT02949843
What this trial is testing

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Who this might be right for
EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 19
Not applicableStudy completedNCT03619980
What this trial is testing

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

Who this might be right for
Prostate Cancer
Astellas Pharma Europe Ltd. 6,908
Post-approval studies (Phase 4)Study completedNCT00363311
What this trial is testing

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 302
Testing effectiveness (Phase 2)Temporarily pausedNCT00568529
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 30
Not applicableStudy completedNCT01071707
What this trial is testing

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 108
Large-scale testing (Phase 3)Ended earlyNCT01200212
What this trial is testing

Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 432
Testing effectiveness (Phase 2)Study completedNCT00595972
What this trial is testing

Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 25
Testing effectiveness (Phase 2)Study completedNCT00747097
What this trial is testing

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study

Who this might be right for
Time to Progression
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Post-approval studies (Phase 4)Study completedNCT02000531
What this trial is testing

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 45
Next Page